Copyright
©The Author(s) 2017.
World J Cardiol. Apr 26, 2017; 9(4): 347-354
Published online Apr 26, 2017. doi: 10.4330/wjc.v9.i4.347
Published online Apr 26, 2017. doi: 10.4330/wjc.v9.i4.347
Figure 1 Association of mortality with Model for End-Stage Liver Disease components and clinical variables.
Figure 2 Association of mortality with total Model for End-Stage Liver Disease score and clinical variables.
Figure 3 Association of mortality with total Model for End-Stage Liver Disease with incorporation of serum sodium score and clinical variables.
- Citation: Kim SM, George B, Alcivar-Franco D, Campbell CL, Charnigo R, Delisle B, Hundley J, Darrat Y, Morales G, Elayi SC, Bailey AL. QT prolongation is associated with increased mortality in end stage liver disease. World J Cardiol 2017; 9(4): 347-354
- URL: https://www.wjgnet.com/1949-8462/full/v9/i4/347.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i4.347